Advisorshares Psychedelics Etf Profile
PSIL Etf | USD 12.18 0.27 2.27% |
Performance5 of 100
| Odds Of DistressLess than 9
|
AdvisorShares Psychedelics is selling for 12.18 as of the 24th of November 2024. This is a 2.27 percent increase since the beginning of the trading day. The etf's lowest day price was 11.8. AdvisorShares Psychedelics has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for AdvisorShares Psychedelics ETF are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of August 2023 and ending today, the 24th of November 2024. Click here to learn more.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. More on AdvisorShares Psychedelics ETF
Moving against AdvisorShares Etf
AdvisorShares Etf Highlights
Thematic Ideas | (View all Themes) |
Business Concentration | Theme ETFs, Strategy ETFs, Miscellaneous Sector, AdvisorShares (View all Sectors) |
Issuer | AdvisorShares |
Inception Date | 2021-09-15 |
Entity Type | Regulated Investment Company |
Asset Under Management | 6.5 Million |
Asset Type | Equity |
Category | Strategy |
Focus | Theme |
Market Concentration | Blended Development |
Region | Global |
Administrator | The Bank of New York Mellon Corporation |
Advisor | AdvisorShares Investments, LLC |
Custodian | The Bank of New York Mellon Corporation |
Distributor | Foreside Fund Services, LLC |
Portfolio Manager | Dan S. Ahrens |
Transfer Agent | The Bank of New York Mellon Corporation |
Fiscal Year End | 30-Jun |
Exchange | NYSE Arca, Inc. |
Number of Constituents | 28.0 |
Market Maker | Virtu Financial |
Total Expense | 3.01 |
Management Fee | 0.6 |
Country Name | USA |
Returns Y T D | (11.17) |
Name | AdvisorShares Psychedelics ETF |
Currency Code | USD |
Open Figi | BBG012JLNFB6 |
In Threey Volatility | 56.84 |
1y Volatility | 69.12 |
200 Day M A | 11.5258 |
50 Day M A | 10.4857 |
Code | PSIL |
Updated At | 23rd of November 2024 |
Currency Name | US Dollar |
In Threey Sharp Ratio | (0.98) |
Type | ETF |
AdvisorShares Psychedelics ETF [PSIL] is traded in USA and was established 2021-09-15. The fund is listed under Miscellaneous Sector category and is part of AdvisorShares family. The entity is thematically classified as Theme ETFs. AdvisorShares Psychedelics at this time have 7.74 M in assets. , while the total return for the last 3 years was -45.8%.
Check AdvisorShares Psychedelics Probability Of Bankruptcy
Geographic Allocation (%)
AdvisorShares Psychedelics Currency Exposure
AdvisorShares Psychedelics ETF holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of AdvisorShares Psychedelics will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in AdvisorShares Psychedelics ETF.
Top AdvisorShares Psychedelics ETF Etf Constituents
ATAI | ATAI Life Sciences | Stock | Health Care | |
RLMD | Relmada Therapeutics | Stock | Health Care | |
GBNH | Greenbrook TMS | Stock | Health Care | |
MNMD | Mind Medicine | Stock | Health Care | |
ALKS | Alkermes Plc | Stock | Health Care | |
SAGE | Sage Therapeutic | Stock | Health Care | |
GHRS | GH Research PLC | Stock | Health Care | |
CMPS | Compass Pathways Plc | Stock | Health Care |
AdvisorShares Psychedelics Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AdvisorShares Psychedelics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
Risk Adjusted Performance | 0.0686 | |||
Jensen Alpha | 1.1 | |||
Total Risk Alpha | (1.03) | |||
Sortino Ratio | 0.2557 |
AdvisorShares Psychedelics Against Markets
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in AdvisorShares Psychedelics ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
The market value of AdvisorShares Psychedelics is measured differently than its book value, which is the value of AdvisorShares that is recorded on the company's balance sheet. Investors also form their own opinion of AdvisorShares Psychedelics' value that differs from its market value or its book value, called intrinsic value, which is AdvisorShares Psychedelics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AdvisorShares Psychedelics' market value can be influenced by many factors that don't directly affect AdvisorShares Psychedelics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AdvisorShares Psychedelics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AdvisorShares Psychedelics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.